Cargando…
Cellular and Molecular Comparison of Glioblastoma Multiform Cell Lines
Glioblastoma multiform (GBM) is one of the most severe tumor types. It is highly invasive and characterized as a grade IV neoplastic cancer. Its resistance to chemotherapy-temozolomide (TMZ treatment)-in combination with tumor treating fields (TTFields), limits the cure of GBM. Therefore researchers...
Autores principales: | Demircan, Turan, Yavuz, Mervenur, Kaya, Egemen, Akgül, Sıddıka, Altuntaş, Ebru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322107/ https://www.ncbi.nlm.nih.gov/pubmed/34345539 http://dx.doi.org/10.7759/cureus.16043 |
Ejemplares similares
-
Hydroquinidine displays a significant anticarcinogenic activity in breast and ovarian cancer cells via inhibiting cell-cycle and stimulating apoptosis
por: YAVUZ, Mervenur, et al.
Publicado: (2023) -
Molecular Characteristics in MRI-Classified Group 1 Glioblastoma Multiforme
por: Haskins, William E., et al.
Publicado: (2013) -
Editorial: Molecular biology of biomarkers in diagnosis and treatment of glioblastoma multiforme
por: Zhao, Jianyi, et al.
Publicado: (2023) -
Proteome data to explore the axolotl limb regeneration capacity at neotenic and metamorphic stages
por: Demircan, Turan, et al.
Publicado: (2020) -
Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme
por: Chin, Christopher, et al.
Publicado: (2018)